vs
Side-by-side financial comparison of Duolingo, Inc. (DUOL) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Duolingo, Inc. is the larger business by last-quarter revenue ($295.5M vs $158.6M, roughly 1.9× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 11.9%, a 59.3% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 27.0%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $103.0M).
Duolingo, Inc. is a leading global edtech firm operating a gamified language learning platform. It offers free and premium self-paced courses for over 40 languages, plus language certification, math learning tools, and literacy programs, serving individual learners, schools and corporate clients worldwide.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
DUOL vs STOK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.5M | $158.6M |
| Net Profit | $35.1M | $112.9M |
| Gross Margin | 55.5% | — |
| Operating Margin | 8.0% | 70.2% |
| Net Margin | 11.9% | 71.2% |
| Revenue YoY | 27.0% | 3661.1% |
| Net Profit YoY | 24.0% | 528.0% |
| EPS (diluted) | $0.72 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $295.5M | — | ||
| Q4 25 | $282.9M | — | ||
| Q3 25 | $271.7M | — | ||
| Q2 25 | $252.3M | — | ||
| Q1 25 | $230.7M | $158.6M | ||
| Q4 24 | $209.6M | $22.6M | ||
| Q3 24 | $192.6M | — | ||
| Q2 24 | $178.3M | — |
| Q1 26 | $35.1M | — | ||
| Q4 25 | $42.0M | — | ||
| Q3 25 | $292.2M | — | ||
| Q2 25 | $44.8M | — | ||
| Q1 25 | $35.1M | $112.9M | ||
| Q4 24 | $13.9M | $-10.5M | ||
| Q3 24 | $23.4M | — | ||
| Q2 24 | $24.4M | — |
| Q1 26 | 55.5% | — | ||
| Q4 25 | 72.8% | — | ||
| Q3 25 | 72.5% | — | ||
| Q2 25 | 72.4% | — | ||
| Q1 25 | 71.1% | — | ||
| Q4 24 | 71.9% | — | ||
| Q3 24 | 72.9% | — | ||
| Q2 24 | 73.4% | — |
| Q1 26 | 8.0% | — | ||
| Q4 25 | 15.4% | — | ||
| Q3 25 | 12.9% | — | ||
| Q2 25 | 13.2% | — | ||
| Q1 25 | 10.2% | 70.2% | ||
| Q4 24 | 6.6% | -60.4% | ||
| Q3 24 | 7.0% | — | ||
| Q2 24 | 10.5% | — |
| Q1 26 | 11.9% | — | ||
| Q4 25 | 14.8% | — | ||
| Q3 25 | 107.5% | — | ||
| Q2 25 | 17.8% | — | ||
| Q1 25 | 15.2% | 71.2% | ||
| Q4 24 | 6.6% | -46.4% | ||
| Q3 24 | 12.1% | — | ||
| Q2 24 | 13.7% | — |
| Q1 26 | $0.72 | — | ||
| Q4 25 | $0.99 | — | ||
| Q3 25 | $5.95 | — | ||
| Q2 25 | $0.91 | — | ||
| Q1 25 | $0.72 | $1.90 | ||
| Q4 24 | $0.31 | $-0.15 | ||
| Q3 24 | $0.49 | — | ||
| Q2 24 | $0.51 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.1B | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $350.1M |
| Total Assets | $2.0B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.0B | — | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $976.2M | — | ||
| Q1 25 | $884.0M | $274.8M | ||
| Q4 24 | $785.8M | $128.0M | ||
| Q3 24 | $854.4M | — | ||
| Q2 24 | $888.2M | — |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $977.0M | — | ||
| Q1 25 | $893.8M | $350.1M | ||
| Q4 24 | $824.5M | $229.0M | ||
| Q3 24 | $822.5M | — | ||
| Q2 24 | $766.9M | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | — | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.4B | $406.9M | ||
| Q4 24 | $1.3B | $271.6M | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.1B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $105.6M | $131.8M |
| Free Cash FlowOCF − Capex | $103.0M | $131.7M |
| FCF MarginFCF / Revenue | 34.9% | 83.0% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | 3.01× | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $368.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $105.6M | — | ||
| Q4 25 | $107.3M | — | ||
| Q3 25 | $84.2M | — | ||
| Q2 25 | $90.7M | — | ||
| Q1 25 | $105.6M | $131.8M | ||
| Q4 24 | $83.3M | $-23.2M | ||
| Q3 24 | $56.3M | — | ||
| Q2 24 | $62.4M | — |
| Q1 26 | $103.0M | — | ||
| Q4 25 | $96.6M | — | ||
| Q3 25 | $79.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $104.3M | $131.7M | ||
| Q4 24 | $81.4M | $-23.2M | ||
| Q3 24 | $53.1M | — | ||
| Q2 24 | $56.8M | — |
| Q1 26 | 34.9% | — | ||
| Q4 25 | 34.1% | — | ||
| Q3 25 | 29.2% | — | ||
| Q2 25 | 35.5% | — | ||
| Q1 25 | 45.2% | 83.0% | ||
| Q4 24 | 38.8% | -102.7% | ||
| Q3 24 | 27.6% | — | ||
| Q2 24 | 31.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.8% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.6% | 0.1% | ||
| Q4 24 | 0.9% | 0.2% | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 3.1% | — |
| Q1 26 | 3.01× | — | ||
| Q4 25 | 2.56× | — | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 2.02× | — | ||
| Q1 25 | 3.01× | 1.17× | ||
| Q4 24 | 5.99× | — | ||
| Q3 24 | 2.41× | — | ||
| Q2 24 | 2.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DUOL
| Bookings | $283.5M | 96% |
| Other | $12.0M | 4% |
STOK
Segment breakdown not available.
